Erythrocyte membrane acetylcholinesterase activity in subjects with MTHFR 677C→T genotype
-
Stylianos Tsakiris
Abstract
Background: Increased homocysteine (Hcy) blood levels are correlated with vascular and neurological problems.
Aim: The aim of the present study was to investigate erythrocyte membrane acetylcholinesterase (AChE) activity in subjects with the MTHFR C677T genotype in relation to Hcy.
Methods: Blood was obtained from 22 individuals with the MTHFR C677T genotype before and after folic acid supplementation and once from controls (n=30). Plasma folate, vitamin B12 and total antioxidant status (TAS) were measured with commercial kits, Hcy by a HPLC method and membrane enzyme activity spectrophotometrically.
Results: In MTHFR C677T carriers, AChE activity was significantly higher (4.20±0.12 
× mg protein) and decreased to normal levels (3.14±0.10 × mg protein; p<0.001) after therapy. TAS differed slightly before and after treatment. Hcy levels were significantly higher before (22.4±2.8μM) compared to after (12.1±2.0μM; p<0.001) therapy and compared to controls (10.5±2.5μmol/L; p<0.001). In an in vitro study, incubation of Hcy-activated membrane AChE from controls with phenylalanine resulted in restoration of activity, but failed to reverse the stimulated enzyme from hyperhomocysteinaemic MTHFR C677T subjects before therapy. Alanine incubation protected the enzyme from Hcy activation in controls.
Conclusions: Increased membrane AChE activity may be due to high Hcy levels. In vitro, phenylalanine reversed the Hcy activation of the membrane enzyme from controls and alanine protected it from Hcy action.
References
1. Lotti M. Cholinesterase inhibition: complexities in interpretation. Clin Chem 1995; 41:1814–8.10.1093/clinchem/41.12.1814Search in Google Scholar
2. Sussman JL, Harel M, Frolow F, Goldman A. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine binding protein. Science 1991; 253:872–9.10.1126/science.1678899Search in Google Scholar
3. Mudd SH, Levy HL, Kran JP. Disorder in transsulfation. In: Scriver CR, Beadet AL, Sly WA, Valle D, editors. The metabolic and molecular bases of inherited diseases, 8th ed. New York: McGraw Hill, 2001:2007–56.Search in Google Scholar
4. Charlton CG, Crowell B Jr. Striatal dopamine, depletion, tremors, and hypokinesia following the intracranial injection of S-adenosylmethionine. A possible role of hypermethylation in Parkinsonism. Mol Chem Neuropathol 1995; 26:269–84.10.1007/BF02815143Search in Google Scholar
5. Kounitiotou-Krontiri P, Tsakiris S, Hadjigeorgiou G. Involvement of sulfhydryl groups in time dependent changes of diaphragm acetylcholinesterase activity by monovalent (Na+, Li+) cations. Biochem Mol Biol Int 1994; 33:485–96.Search in Google Scholar
6. Tsakiris S, Angelogianni P, Schulpis KH, Stavridis J. Protective effect of L-phenylalanine on rat brain acetylcholinesterase inhibition induced by free radicals. Clin Biochem 2000; 33:103–6.10.1016/S0009-9120(99)00090-9Search in Google Scholar
7. Tsakiris S, Schulpis KH. Alanine reverses the inhibitory effect of phenylalanine on acetylcholinesterase activity. Z Naturforsch 2002; 57c:506–11.10.1515/znc-2002-5-618Search in Google Scholar
8. Streck E, Zugno AI, Tagliari B, Sarkis J, Wajner M, Wannmacher C, et al. On the mechanism of the inhibition of Na+, K+ ATPase activity caused by homocysteine. Int J Dev Neurosci 2002; 20:77–81.10.1016/S0736-5748(02)00043-6Search in Google Scholar
9. Weisberg IS, Jacques PF, Selhub J, Bostom AG, Chen Z, Curtis Ellison R, et al. The 1298 A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001; 156:409–15.10.1016/S0021-9150(00)00671-7Search in Google Scholar
10. Stefanello FM, Franzon R, Tagliari B, Wannmacher C, Wajner M, Wyse AT. Reduction of butyrylcholinesterase activity in rat serum subjected to homocysteinemia. Metab Brain Dis 2005; 20:97–103.10.1007/s11011-005-4147-5Search in Google Scholar
11. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001; 22:195–201.10.1016/S0165-6147(00)01675-8Search in Google Scholar
12. Papoutsakis C, Yiannakouris N, Manios Y, Papakonstantinou E, Magkos F, Schulpis KH, et al. Plasma homocysteine concentrations in a Mediterranean pediatric population are influenced by an interaction between the methylenetetrahydrofolate reductase 677 C→T genotype and folate status. J Nutr 2005; 135:383–8.10.1093/jn/135.3.383Search in Google Scholar PubMed
13. Antoniadi T, Hadzis T, Kroupis C, Economou-Petersen E, Petersen MB. Prevalence of Factor V Leiden, Prothrombin G 20210 A, and MTHFR C677T mutations in a Greek population of blood donors. Am J Hematol 1999; 61:265–7.10.1002/(SICI)1096-8652(199908)61:4<265::AID-AJH8>3.0.CO;2-#Search in Google Scholar
14. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraki FM, Malinow MR. Vascular dysfunction in monkeys with diet induced hyperhomocysteinemia. J Clin Invest 1996; 98:24–9.10.1172/JCI118771Search in Google Scholar
15. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocysteinaemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997; 95:1119–21.10.1161/01.CIR.95.5.1119Search in Google Scholar
16. McCully KS. Pathology of homocysteinuria, in: Homocysteine metabolism: From basic science to clinical medicine. Dordrecht: Kluwer, 1997:251–257.Search in Google Scholar
17. Olszewski AJ, McCully KS. Homocysteine metabolism and the oxidative modification of proteins and lipids. Free Radic Biol Med 1993; 14:763–93.Search in Google Scholar
18. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection. J Chromatogr 1987; 422:43–52.10.1016/0378-4347(87)80438-3Search in Google Scholar
19. Saiki PK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic application of DNA with a thermostable DNA polymerase. Science 1988; 239:487–91.10.1126/science.2448875Search in Google Scholar
20. Schulpis KH, Tsakiris S, Karikas GA, Moukas M, Behrakis P. Effect of diet on plasma total antioxidant status in phenylketonuric patients. Eur J Clin Nutr 2003; 57:383–7.10.1038/sj.ejcn.1601529Search in Google Scholar
21. Strube M, Haenen GR, Van den Berg H, Bast A. Pitfalls in a method for assessment of total antioxidant capacity. Free Radic Res 1997; 26:515–21.10.3109/10715769709097822Search in Google Scholar
22. Galbraith DA, Watts DC. Changes in some cytoplasmic enzymes from red cells fractionated into age groups by centrifugation in Ficoll/Triosil gradients. Comparison of normal humans and patients with Duchenne muscular dystrophy. Biochem J 1980; 191:63–70.10.1042/bj1910063Search in Google Scholar
23. Kamber E, Poyiagi A, Deliconstantinos D. Modifications in the activities of membrane-bound enzymes during in vivo ageing of human and rabbit erythrocytes. Comp Biochem Physiol 1984; 77B:95–9.10.1016/0305-0491(84)90228-1Search in Google Scholar
24. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265–75.10.1016/S0021-9258(19)52451-6Search in Google Scholar
25. Ellman GI, Courtney D, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7:88–95.10.1016/0006-2952(61)90145-9Search in Google Scholar
26. Bottiglieri T, Parnetti L, Arning E, Ortiz T, Amici S, Lenari A, et al. Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate (MTHFR) gene: A study in an Italian population with dementia. Mech Ageing Dev 2001; 122:2013–23.10.1016/S0047-6374(01)00307-4Search in Google Scholar
27. Leblhuber F, Walli J, Widner B, Artner-Dworzak E, Fuchs O, Vrecko K. Homocysteine and B vitamins in dementia. Am J Clin Nutr 2001; 73:127–8.10.1093/ajcn/73.1.127Search in Google Scholar PubMed
28. Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L, Novembrino C, et al. Oxidative stress and homocysteine in coronary artery disease. Clin Chem 2001; 47:887–92.10.1093/clinchem/47.5.887Search in Google Scholar
©2006 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Where does the evidence come from?
- NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancer
- Plasma cell-free DNA as an indicator of severity of injury in burn patients
- Bivariate statistical approach to evaluate laboratory performance by analysis of standard curves in an External Quality Assurance program for quantitative assays based on real-time PCR with Taq-Man™ probes
- Erythrocyte membrane acetylcholinesterase activity in subjects with MTHFR 677C→T genotype
- Plasma levels of tumor M2-pyruvate kinase should not be used as a tumor marker for hematological malignancies and solid tumors
- APO A-V–1131T→C polymorphism frequency and its association with morbidity in a Brazilian elderly population
- Association study between fibronectin and coronary heart disease
- Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins
- Urinary calcium excretion in severe preeclampsia and eclampsia
- In vitro re-mineralization of demineralized bone matrix in human serum
- Measurement of serum amyloid A1 (SAA1), a major isotype of acute phase SAA
- Disturbed lipoprotein composition in non-dialyzed, hemodialysis, continuous ambulatory peritoneal dialysis and post-transplant patients with chronic renal failure
- Measurement of serum testosterone using high-performance liquid chromatography/tandem mass spectrometry
- Quantitative bacterial micro-assay for rapid detection of serum phenylalanine on dry blood-spots: application in phenylketonuria screening
- N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability
- A new quality control model using performance goals based on biological variation in External Quality Assurance Schemes
- Improvement in glycemic control over 11 years in patients monitored for diabetes in one county
- The clinical usefulness of glucose tolerance testing in gestational diabetes to predict early postpartum diabetes mellitus
- Analytical performance of a new two-step ADVIA Centaur® estradiol immunoassay during ovarian stimulation
- EC4 European Syllabus for Post-Graduate Training in Clinical Chemistry and Laboratory Medicine: version 3 – 2005
- POX-Act assay and d-ROMs test – what are the facts?
- External quality control of urinary methyl malonic acid quantification – announcement of a pilot study
Articles in the same Issue
- Where does the evidence come from?
- NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancer
- Plasma cell-free DNA as an indicator of severity of injury in burn patients
- Bivariate statistical approach to evaluate laboratory performance by analysis of standard curves in an External Quality Assurance program for quantitative assays based on real-time PCR with Taq-Man™ probes
- Erythrocyte membrane acetylcholinesterase activity in subjects with MTHFR 677C→T genotype
- Plasma levels of tumor M2-pyruvate kinase should not be used as a tumor marker for hematological malignancies and solid tumors
- APO A-V–1131T→C polymorphism frequency and its association with morbidity in a Brazilian elderly population
- Association study between fibronectin and coronary heart disease
- Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins
- Urinary calcium excretion in severe preeclampsia and eclampsia
- In vitro re-mineralization of demineralized bone matrix in human serum
- Measurement of serum amyloid A1 (SAA1), a major isotype of acute phase SAA
- Disturbed lipoprotein composition in non-dialyzed, hemodialysis, continuous ambulatory peritoneal dialysis and post-transplant patients with chronic renal failure
- Measurement of serum testosterone using high-performance liquid chromatography/tandem mass spectrometry
- Quantitative bacterial micro-assay for rapid detection of serum phenylalanine on dry blood-spots: application in phenylketonuria screening
- N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability
- A new quality control model using performance goals based on biological variation in External Quality Assurance Schemes
- Improvement in glycemic control over 11 years in patients monitored for diabetes in one county
- The clinical usefulness of glucose tolerance testing in gestational diabetes to predict early postpartum diabetes mellitus
- Analytical performance of a new two-step ADVIA Centaur® estradiol immunoassay during ovarian stimulation
- EC4 European Syllabus for Post-Graduate Training in Clinical Chemistry and Laboratory Medicine: version 3 – 2005
- POX-Act assay and d-ROMs test – what are the facts?
- External quality control of urinary methyl malonic acid quantification – announcement of a pilot study
